First-line chemotherapy in low-risk gestational trophoblastic neoplasia

Author:

Lawrie Theresa A1,Alazzam Mo'iad2,Tidy John3,Hancock Barry W4,Osborne Raymond5

Affiliation:

1. 1st Floor Education Centre, Royal United Hospital; Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group; Combe Park Bath UK BA1 3NG

2. Beacon Hospital; Gynaecological Oncology Division; Sandyford Dublin Ireland 18

3. Sheffield Teaching Hospitals Foundation NHS Trust; Obstetrics & Gynaecology; Royal Hallamshire Hospital Glossop Road Sheffield UK S10 2JF

4. Sheffield University; School of Medicine and Biomedical Sciences; Western Bank Sheffield UK S10 2TN

5. Toronto-Sunnybrook Regional Cancer Centre; Division of Gynecology-Oncology; 2075 Bayview Ave Toronto ON Canada M4N 3M5

Publisher

Wiley

Subject

Pharmacology (medical)

Reference82 articles.

1. Gilani MM Yarandi F Eftekhar Z Hanjani P Comparison of pulse methotrexate and pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia Australian and New Zealand Journal of Obstetrics and Gynaecology 2005 161 4

2. Lertkhachonsuk A Tangtrakul S Israngura N Wilailak S Actinomycin D versus methotrexate-folinic acid as the treatment of stage 1, low-risk gestational trophoblastic neoplasia Conference abstract from the International Society for the Study of Trophoblastic Disease (ISSTD) conference 2007

3. Actinomycin d versus methotrexate-folinic acid as the treatment of stage I, low-risk gestational trophoblastic neoplasia: a randomized controlled trial;Lertkhachonsuk;International Journal of Gynecological Cancer,2009

4. Comparison of pulsed actinomycin D versus 5-day methotrexate for the treatment of low-risk gestational trophoblastic disease;Mousavi;International Journal of Gynecology and Obstetrics,2012

5. Osborne R Filiaci V Schink J Mannel R Provencher D Alvarez-Secord A A randomized phase III trial comparing weekly parenteral methotrexate and “pulsed” actinomycin D as primary management for low-risk gestational trophoblastic neoplasia: A Gynecologic Oncology Group study Gynecologic Oncology 2008 S2 S31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3